146 related articles for article (PubMed ID: 18329171)
1. NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease.
Napolitano M; Zei D; Centonze D; Palermo R; Bernardi G; Vacca A; Calabresi P; Gulino A
Neurosci Lett; 2008 Apr; 434(3):241-6. PubMed ID: 18329171
[TBL] [Abstract][Full Text] [Related]
2. Signaling mechanisms of interferon gamma induced apoptosis in chromaffin cells: involvement of nNOS, iNOS, and NFkappaB.
Pérez-Rodríguez R; Roncero C; Oliván AM; González MP; Oset-Gasque MJ
J Neurochem; 2009 Feb; 108(4):1083-96. PubMed ID: 19141072
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease.
Napolitano M; Costa L; Palermo R; Giovenco A; Vacca A; Gulino A
Brain Res Bull; 2011 May; 85(3-4):231-7. PubMed ID: 21440606
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
6. Time-related changes in constitutive and inducible nitric oxide synthases in the rat striatum in a model of Huntington's disease.
Aguilera P; Chánez-Cárdenas ME; Floriano-Sánchez E; Barrera D; Santamaría A; Sánchez-González DJ; Pérez-Severiano F; Pedraza-Chaverrí J; Jiménez PD
Neurotoxicology; 2007 Nov; 28(6):1200-7. PubMed ID: 17850874
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
[TBL] [Abstract][Full Text] [Related]
8. The role of nitric oxide synthases in pemphigus vulgaris in a mouse model.
Marquina M; España A; Fernández-Galar M; López-Zabalza MJ
Br J Dermatol; 2008 Jul; 159(1):68-76. PubMed ID: 18476963
[TBL] [Abstract][Full Text] [Related]
9. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
Pandey M; Varghese M; Sindhu KM; Sreetama S; Navneet AK; Mohanakumar KP; Usha R
J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
[TBL] [Abstract][Full Text] [Related]
11. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta (25-35) increases activity of neuronal NO-synthase in rat brain.
Stepanichev MY; Onufriev MV; Yakovlev AA; Khrenov AI; Peregud DI; Vorontsova ON; Lazareva NA; Gulyaeva NV
Neurochem Int; 2008 May; 52(6):1114-24. PubMed ID: 18207612
[TBL] [Abstract][Full Text] [Related]
13. Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells.
Shen J; Lee W; Li Y; Lau CF; Ng KM; Fung ML; Liu KJ
J Neurochem; 2008 Oct; 107(2):478-87. PubMed ID: 18717816
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of 3-nitropropionic acid-induced membrane permeability transition of isolated mitochondria and its suppression by L-carnitine.
Nishimura M; Okimura Y; Fujita H; Yano H; Lee J; Suzaki E; Inoue M; Utsumi K; Sasaki J
Cell Biochem Funct; 2008 Dec; 26(8):881-91. PubMed ID: 18942062
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB and NOS may play a role in human RPMI-8402 cell apoptosis.
Trubiani O; Salvolini E; Vignini A; D'Arcangelo C; Di Primio R; Mazzanti L
Cell Biol Int; 2005 Jul; 29(7):529-36. PubMed ID: 15919216
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inducible nitric oxide synthase by Acanthopanax senticosus extract in RAW264.7 macrophages.
Lin QY; Jin LJ; Cao ZH; Xu YP
J Ethnopharmacol; 2008 Jul; 118(2):231-6. PubMed ID: 18486372
[TBL] [Abstract][Full Text] [Related]
17. Role of nitric oxide and nuclear factor-kappaB in the CYP2E1 potentiation of tumor necrosis factor alpha hepatotoxicity in mice.
Wu D; Xu C; Cederbaum A
Free Radic Biol Med; 2009 Feb; 46(4):480-91. PubMed ID: 19063961
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide triggers delayed anesthetic preconditioning-induced cardiac protection via activation of nuclear factor-kappaB and upregulation of inducible nitric oxide synthase.
Chen CH; Chuang JH; Liu K; Chan JY
Shock; 2008 Sep; 30(3):241-9. PubMed ID: 18708911
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease.
Yu Z; Zhou D; Cheng G; Mattson MP
J Mol Neurosci; 2000 Aug; 15(1):31-44. PubMed ID: 11211235
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
Chang KL; New LS; Mal M; Goh CW; Aw CC; Browne ER; Chan EC
J Proteome Res; 2011 Apr; 10(4):2079-87. PubMed ID: 21355552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
